Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel SLC25A1 inhibitor, parthenolide, suppresses the growth and stemness of liver cancer stem cells with metabolic vulnerability
Zhichun Zhang, Yuan Qiao, Qiuyue Sun, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition
Andrey V. Markov, Arseny D. Moralev, Kirill V. Odarenko
Biomedicines (2025) Vol. 13, Iss. 1, pp. 133-133
Open Access
SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation
Wei Li, Jing Han, Bin Huang, et al.
The EMBO Journal (2025)
Closed Access
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment
Haoqiang Yang, Jinghui Li, Yuanjie Niu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes
Benjamin N. Gantner, Flávio R. Palma, Madhura R. Pandkar, et al.
Trends in cancer (2024) Vol. 10, Iss. 11, pp. 992-1008
Closed Access | Times Cited: 3
Exploring the anticancer mechanism of cardiac glycosides using proteome integral solubility alteration approach
Wenjie Qin, Yinhua Deng, Huan Ren, et al.
Cancer Medicine (2024) Vol. 13, Iss. 18
Open Access | Times Cited: 2
Computational analysis of ligands from natural products on the cellular targets of combined hepatocellular carcinoma and cholangiocarcinoma
Damita Rai, S. George
Natural Product Research (2024), pp. 1-9
Closed Access | Times Cited: 1
Inhibitory Activity of Compounds Isolated from Ligustrum robustum (Roxb.) against HepG2 Liver Cancer Cells: Isocubein and 4‐(2‐Acetoxyethyl)phenol as Potential Candidates
Thi Anh Thu Nong, Lê Thị Hương, Van Tuan Vu, et al.
Chemistry & Biodiversity (2024)
Closed Access | Times Cited: 1
Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways
Jianxin Guo, Ming Huang, Shuang Hou, et al.
Cancer Reports (2024) Vol. 7, Iss. 9
Open Access | Times Cited: 1
The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives
Amer Ahmed, Giorgia Natalia Iaconisi, Daria Di Molfetta, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 92-92
Open Access
Central carbon metabolism exhibits unique characteristics during the handling of fungal patterns by monocyte-derived dendritic cells
Yolanda Álvarez, Cristina Mancebo, Sara Alonso, et al.
Redox Biology (2024) Vol. 73, pp. 103187-103187
Open Access
Gastric adenocarcinoma predictive long intergenic noncoding RNA (GAPLINC) promotes oral cancer stemness by acting as a molecular sponge of miR331-3p
Kuang-Yuan Liang, Ni‐Yu Su, Hsiu-Pin Yang, et al.
Journal of Dental Sciences (2024) Vol. 19, Iss. 3, pp. 1389-1395
Open Access
SLC25 family with energy metabolism and immunity in malignant tumors
Guiqian Zhang, Ning Wang, Shi‐Xun Ma, et al.
ONCOLOGIE (2023) Vol. 26, Iss. 1, pp. 65-77
Open Access | Times Cited: 1
Page 1

Scroll to top